[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100390842":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":35,"collaborators":7,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":7,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":7,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":7,"overallStatus":16,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"First Affiliated Hospital of Fujian Medical University","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":12,"email":13},"Ning Wang","CONTACT","13805015340","ningwang@fjmu.edu.cn",[15],{"facility":5,"status":16,"city":17,"state":18,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"RECRUITING","Fuzhou","Fujian","350005","China","CN",{"type":23,"coordinates":24},"Point",[25,26],119.30611,26.06139,{"lat":26,"lon":25},[29,33],{"name":30,"role":11,"phone":31,"phoneExt":31,"email":32},"Zhiqiang Wang","08659187982772","fmuwzq@fjmu.edu.cn",{"name":30,"role":34,"phone":7,"phoneExt":7,"email":7},"SUB_INVESTIGATOR",{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","Ning Wang, MD., PhD.","Professor","100390842","a-registered-cohort-study-on-fshd1-100390842",false,"NCT04369209","A Registered Cohort Study on FSHD1","A Registered Observational Cohort Study of Facioscapulohumeral Muscular Dystrophy Type 1","Inclusion Criteria:\n\n* Male or female subjects of all ages at baseline\n* Subjects, with or without symptoms, with FSHD1 genetic confirmation through PFGE-based Southern blotting\n* Unrelated healthy controls\n\nExclusion Criteria:\n\n* Decline to participate\n* Other neuromuscular disease (such as Limb-girdle muscular dystrophy or Myotonic dystrophy)\n* Serious systemic illness (such as heart, liver, kidney disease or major mental illness)",true,"ALL",{"count":49,"type":50},1000,"ESTIMATED","OBSERVATIONAL","The data to be collected is intended to help healthcare providers make important medical and financial decisions concerning FSHD1, through an enhanced understanding of the prevalence, progression and natural history of FSHD1.",[54],"Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)","2024-08-23",{"date":57,"type":58},"2024-08-26","ACTUAL",{"date":60,"type":58},"2001-01",{"date":62,"type":50},"2031-12",{"name":37,"class":6},1]